The number of dopaminergic cells is increased in the olfactory bulb of monkeys chronically exposed to MPTP
- PMID: 17853434
- DOI: 10.1002/syn.20451
The number of dopaminergic cells is increased in the olfactory bulb of monkeys chronically exposed to MPTP
Abstract
We investigated the impact of the nigrostriatal lesion on the olfactory tyrosine hydroxylase-immunoreactive (TH-ir) cells in monkeys. The majority of these TH-ir cells appeared in the glomerular layer of the olfactory bulb and many were immature but functional dopaminergic neurons. In parkinsonian monkeys the number of olfactory dopaminergic neurons increased up to 100% as compared to controls, but their phenotype did not change. This increased TH-ir cell population might be a direct consequence of the nigral cell loss and contribute to the hyposmia reported by Parkinson's disease patients.
(c) 2007 Wiley-Liss, Inc.
Similar articles
-
Modification of the number and phenotype of striatal dopaminergic cells by carotid body graft.Brain. 2007 May;130(Pt 5):1306-16. doi: 10.1093/brain/awm061. Epub 2007 Apr 17. Brain. 2007. PMID: 17439984
-
The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation.Eur J Neurosci. 2005 Jul;22(2):317-30. doi: 10.1111/j.1460-9568.2005.04220.x. Eur J Neurosci. 2005. PMID: 16045485
-
A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets.Eur J Neurosci. 2005 Feb;21(4):841-54. doi: 10.1111/j.1460-9568.2005.03915.x. Eur J Neurosci. 2005. PMID: 15787691
-
Dopaminergic cells in the periaqueductal grey matter of MPTP-treated monkeys and mice; patterns of survival and effect of deep brain stimulation and lesion of the subthalamic nucleus.Parkinsonism Relat Disord. 2010 Jun;16(5):338-44. doi: 10.1016/j.parkreldis.2010.02.008. Epub 2010 Mar 12. Parkinsonism Relat Disord. 2010. PMID: 20227323
-
Calcitonin gene-related peptide influence on central nervous system differentiation.Ann N Y Acad Sci. 1992 Jun 30;657:344-50. doi: 10.1111/j.1749-6632.1992.tb22781.x. Ann N Y Acad Sci. 1992. PMID: 1379017 Review. No abstract available.
Cited by
-
Calcium homeostasis, selective vulnerability and Parkinson's disease.Trends Neurosci. 2009 May;32(5):249-56. doi: 10.1016/j.tins.2009.01.006. Epub 2009 Mar 21. Trends Neurosci. 2009. PMID: 19307031 Free PMC article. Review.
-
The role of free radicals in the aging brain and Parkinson's Disease: convergence and parallelism.Int J Mol Sci. 2012;13(8):10478-10504. doi: 10.3390/ijms130810478. Epub 2012 Aug 21. Int J Mol Sci. 2012. PMID: 22949875 Free PMC article. Review.
-
Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease.Cell Calcium. 2010 Feb;47(2):175-82. doi: 10.1016/j.ceca.2009.12.003. Epub 2010 Jan 6. Cell Calcium. 2010. PMID: 20053445 Free PMC article. Review.
-
Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.J Neural Transm (Vienna). 2018 Mar;125(3):337-363. doi: 10.1007/s00702-017-1774-z. Epub 2017 Aug 31. J Neural Transm (Vienna). 2018. PMID: 28861737 Free PMC article. Review.
-
Characterization of nonmotor behavioral impairments and their neurochemical mechanisms in the MitoPark mouse model of progressive neurodegeneration in Parkinson's disease.Exp Neurol. 2021 Jul;341:113716. doi: 10.1016/j.expneurol.2021.113716. Epub 2021 Apr 8. Exp Neurol. 2021. PMID: 33839143 Free PMC article.